High-dose paclitaxel plus G-CSF for malignant mesothelioma: CALGB phase II study 9234

N. J. Vogelzang, J. E. Herndon, A. Miller, G. Strauss, G. Clamon, F. M. Stewart, J. Aisner, A. Lyss, M. R. Cooper, Y. Suzuki, M. R. Green

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Fingerprint Dive into the research topics of 'High-dose paclitaxel plus G-CSF for malignant mesothelioma: CALGB phase II study 9234'. Together they form a unique fingerprint.

Medicine & Life Sciences